G-CSF Moblized Peripheral Harvest for Poor Engraftment After Stem Cell Transplantation
NCT01857336 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2020-09-25
Summary
Poor graft function (PGF) is a common complication after allogeneic stem cell transplantation, which was associated with high mortality. The pathogenesis fo PGF was poorly understood. Infusion of donor peripheral cell harvest was effective for some patients with PGF in our preliminary study. This present study aimed to explore the efficacy of peripheral cell harvest for poor graft function.
Conditions
- Poor Graft Function
- Stem Cell Transplantation
- Graft Versus Host Disease
Interventions
- OTHER
-
infusion of G-CSF mobilized peripheral harvest
Sponsors & Collaborators
-
Peking University People's Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 14 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-03-01
- Primary Completion
- 2020-08-31
- Completion
- 2020-08-31
Countries
- China
Study Locations
More Related Trials
-
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
NCT00001529 ·Status: RECRUITING
-
Second Transplantation for Graft Failure
NCT03717545 ·Status: UNKNOWN ·Phase: NA
-
Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation
NCT01086735 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function
NCT00603330 ·Status: RECRUITING ·Phase: PHASE2
-
Collection of Peripheral Blood Stem Cells Using G-CSF and Plerixafor in Normal Volunteers
NCT01123499 ·Status: TERMINATED
-
PEG-rhG-CSF Compared With rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation
NCT05156554 ·Status: UNKNOWN ·Phase: NA
-
G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers
NCT00082329 ·Status: COMPLETED ·Phase: PHASE2
-
Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)
NCT00231309 ·Status: COMPLETED ·Phase: NA
-
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
NCT00253552 ·Status: TERMINATED ·Phase: NA
-
Efficacy Study of Low-dose Glucocorticoid Prophylaxis for Acute Graft-versus-host Disease(GVHD)
NCT01607580 ·Status: COMPLETED ·Phase: NA
-
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
NCT02167958 ·Status: COMPLETED ·Phase: PHASE1
-
T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplastic Anemia
NCT00002718 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies
NCT00113646 ·Status: TERMINATED ·Phase: PHASE2
-
Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation
NCT02258490 ·Status: NO_LONGER_AVAILABLE
-
Modified Second Haplo-transplantation for Graft Failure
NCT06512545 ·Status: RECRUITING ·Phase: NA
-
Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer
NCT00627666 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell
NCT00447460 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants
NCT00001830 ·Status: COMPLETED ·Phase: PHASE1
-
Collection of Bone Marrow From Donors Treated With or Without Filgrastim
NCT01149096 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease
NCT00972660 ·Status: UNKNOWN ·Phase: PHASE2
-
AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts
NCT00396331 ·Status: COMPLETED ·Phase: PHASE2
-
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
NCT06001385 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies
NCT02566395 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF
NCT00952237 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children
NCT00695370 ·Status: TERMINATED ·Phase: PHASE2